Framycetin is an aminoglycoside antibiotic primarily utilized in topical preparations for the treatment of bacterial infections affecting the skin, ears, and eyes, such as infected wounds, ulcers, and… Read more
Framycetin is an aminoglycoside antibiotic primarily utilized in topical preparations for the treatment of bacterial infections affecting the skin, ears, and eyes, such as infected wounds, ulcers, and burns. It functions by inhibiting bacterial protein synthesis through binding to the 30S ribosomal subunit, thereby effectively curbing the growth of susceptible aerobic bacteria. This category provides essential reference standards for framycetin, including its pharmaceutical impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for laboratories engaged in rigorous analytical testing, impurity profiling, and method validation to ensure the efficacy and safety of pharmaceutical products. By facilitating precise identification and quantification of related substances, these reference compounds support comprehensive quality control protocols throughout the pharmaceutical development and manufacturing lifecycle.